150
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis strategies for optimizing sizes of PLGA nanoparticles containing recombinant Chenopodium album (rChe a 3) allergen

, , &
Pages 603-608 | Received 17 Jul 2016, Accepted 20 Oct 2016, Published online: 04 May 2017

References

  • Schmitt, J.; Schwarz, K.; Stadler, E.; Wustenberg, E. G. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: Results from a large retrospective cohort study. J. Allergy Clin. Immunol. 2015, 136, 1511–1516.
  • Zhang, Z.; Guo, Y.; Feng, S. S. Nanoimmunotherapy: Application of nanotechnology for sustained and targeted delivery of antigens to dendritic cells. Nanomedicine (Lond). 2012, 7, 1–4.
  • Peek, L. J.; Middaugh, C. R.; Berkland, C. Nanotechnology in vaccine delivery. Adv. Drug Deliv. Rev. 2008, 60, 915–928.
  • Spiers, I. D.; Eyles, J. E.; Baillie, L. W.; Williamson, E. D.; Alpar, H. O. Biodegradable microparticles with different release profiles: effect on the immune response after a single administration via intranasal and intramuscular routes. J. Pharm. Pharmacol. 2000, 52, 1195–1201.
  • Rosas, J. E.; Hernandez, R. M.; Gascon, A. R.; Igartua, M.; Guzman, F.; Patarroyo, M. E.; Pedraz, J. L. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66. Vaccine. 2001, 19, 4445–4451.
  • Igartua, M.; Hernandez, R. M.; Esquisabel, A.; Gascon, A. R.; Calvo, M. B.; Pedraz, J. L. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres. J. Control Release 1998, 56, 63–73.
  • Combadiere, B.; Mahe, B. Particle-based vaccines for transcutaneous vaccination. Comp. Immunol. Microbiol. Infect. Dis. 2008, 31, 293–315.
  • Win, K. Y.; Feng, S. S. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005, 26, 2713–2722.
  • Shen, H.; Ackerman, A. L.; Cody, V.; Giodini, A.; Hinson, E. R.; Cresswell, P.; Edelson, R. L.; Saltzman, W. M.; Hanlon, D. J. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology 2006, 117, 78–88.
  • Gutierro, I.; Hernandez, R. M.; Igartua, M.; Gascon, A. R.; Pedraz, J. L. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine 2002, 21, 67–77.
  • Salari, F.; Varasteh, A. R.; Vahedi, F.; Hashemi, M.; Sankian, M. Down-regulation of Th2 immune responses by sublingual administration of poly (lactic-co-glycolic) acid (PLGA)-encapsulated allergen in BALB/c mice. Int. Immunopharmacol. 2015, 29, 672–678.
  • Nouri, H. R.; Sankian, M.; Vahedi, F.; Afsharzadeh, D.; Rouzbeh, L.; Moghadam, M.; Varasteh, A. Diagnosis of Chenopodium album allergy with a cocktail of recombinant allergens as a tool for component-resolved diagnosis. Mol. Biol. Rep. 2012, 39, 3169–3178.
  • Holzer, M.; Vogel, V.; Mantele, W.; Schwartz, D.; Haase, W.; Langer, K. Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage. Eur. J. Pharm. Biopharm. 2009, 72, 428–437.
  • Fonte, P.; Soares, S.; Costa, A.; Andrade, J. C.; Seabra, V.; Reis, S.; Sarmento, B. Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-drying. Biomaterials 2012, 2, 329–339.
  • Cheng, J.; Teply, B. A.; Sherifi, I.; Sung, J.; Luther, G.; Gu, F. X. Levy-Nissenbaum E., Radovic-Moreno A. F., Langer R., Farokhzad O. C. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials. 2007, 28, 869–876.
  • Ranjan, A. P.; Mukerjee, A.; Helson, L.; Vishwanatha, J. K. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. J. Nanobiotechno. 2012, 10, 38.
  • Chung, T. W.; Tsai, Y. L.; Hsieh, J. H.; Tsai, W. J. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives. J. Microencapsul. 2006, 23, 15–27.
  • Yang, Y. Y.; Chung, T. S.; Ng, N. P. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001, 22, 231–241.
  • Ma, P.; Mumper, R. J. Paclitaxel nano-delivery systems: A comprehensive review. J. Nanomed. Nanotechnol. 2013, 4, 1000164.
  • Mora-Huertas, C. E.; Fessi, H.; Elaissari, A. Polymer-based nanocapsules for drug delivery. Int. J. Pharm. 2010, 385, 113–142.
  • Li, M.; Rouaud, O.; Poncelet, D. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int. J. Pharm. 2008, 363, 26–39.
  • Sahoo, S. K.; Panyam, J.; Prabha, S.; Labhasetwar, V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Control Release. 2002, 82, 105–114.
  • Jalil, R.; Nixon, J. R. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: Problems associated with preparative techniques and release properties. J. Microencapsul. 1990, 7, 297–325.
  • Song, X.; Zhao, Y.; Hou, S.; Xu, F.; Zhao, R.; He, J.; Cai, Z.; Li, Y.; Chen, Q. Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. Eur. J. Pharm. Biopharm. 2008, 69, 445–453.
  • Song, X.; Zhao, Y.; Wu, W.; Bi, Y.; Cai, Z.; Chen, Q.; Li, Y.; Hou, S. PLGA nanoparticles simultaneously loaded with vincristine sulfate; and verapamil hydrochloride: Systematic study of particle size; and drug entrapment efficiency. Int. J. Pharm. 2008, 350, 320–329.
  • Wang, H.; Jia, Y.; Hu, W.; Jiang, H.; Zhang, J.; Zhang, L. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin. Pharm. Dev. Technol. 2013, 18, 694–700.
  • Narayanan, K.; Subrahmanyam, V. M.; Venkata Rao, J. A fractional factorial design to study the effect of process variables on the preparation of hyaluronidase loaded PLGA nanoparticles. Enz. Res. 2014, 2014, 162962.
  • Zweers, M. L.; Grijpma, D. W.; Engbers, G. H.; Feijen, J. The preparation of monodisperse biodegradable polyester nanoparticles with a controlled size. J. Biomed. Mater. Res. B Appl. Biomater. 2003, 66, 559–566.
  • Sengel Türk, C. T.; Sezgin Bayindir, Z.; Badilli, U. Preparation of polymeric nanoparticles using different stabilizing agents. J. Fac. Pharm. Ankara. 2009, 38, 257–268.
  • Maia, J. L.; Santana, M. H. A.; Ré, M. I. The effect of some processing conditions on the characteristics of biodegradable microspheres obtained by an emulsion solvent evaporation process. Braz. J. Chem. Eng. 2004, 21, 01–12.
  • Hideki, M.; Yoshiaki, K.; Toshiyuki, N.; Tomoaki, H.; Hirofumi, T.; Masao, K. Influence of the degrees of hydrolyzation and polymerization of poly (vinylalcohol) on the preparation and properties of poly (DL-lactide-co-glycolide) nanoparticle. Int. J. Pharm. 1997, 149, 43–49.
  • Manisha, K.; Maheshwar, S.; Madhuri, S. Encapsulation of berberine in nano-sized PLGA synthesized by emulsification method. ISRN Nanotechnol. 2012, 2012, 1–9.
  • Jeong, Y. I.; Song, J. G., Kang S. S.; Ryu, H. H.; Lee, Y. H.; Choi, C.; Shin, B. A.; Kim, K. K.; Ahn, K. Y.; Jung, S. Preparation of poly(DL-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid. Int. J. Pharm. 2003, 259, 79–91.
  • Song, C. X., Labhasetwar, V., Murphy, H., Qu, X., Humphrey, W. R., Shebuski, R. J., Levy, R. J. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J. Control. Release 1997, 43, 197–212.
  • Sengel, C.; Hascicek, C.; Gonul, N. Design of vitamin E d-alpha-Tocopheryl polyethylene glycol 1000 succinate-emulsified poly (D,L-Lactide-co-Glycolide) nanoparticles: Influence of duration of ultrasonication energy. J. Young Pharm. 2011, 3, 171–175.
  • Budhian, A.; Siegel, S. J.; Winey, K. I. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int. J. Pharm. 2007, 336, 367–375.
  • Cun, D.; Foged, C.; Yang, M.; Frokjaer, S.; Nielsen, H. M. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery. Int. J. Pharm. 2010, 390, 70–75.
  • Hilbert, A. K.; Fritzsche, U.; Kissel, T. Biodegradable microspheres containing influenza A vaccine: Immune response in mice. Vaccine 1999, 17, 1065–1073.
  • Dawes, G. J.; Fratila-Apachitei, L. E.; Necula, B. S.; Apachitei, I.; Witkamp, G. J.; Duszczyk, J. Release of PLGA-encapsulated dexamethasone from microsphere loaded porous surfaces. J. Mater. Sci. Mater. Med. 2010, 21, 215–221.
  • Liu, J.; Zhang, S. M.; Chen, P. P.; Cheng, L.; Zhou, W.; Tang, W. X.; Chen, Z. W.; Ke, C. M. Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels. J. Mater. Sci. Mater. Med. 2007, 18, 2205–2210.
  • Lemoine, D.; Francois, C.; Kedzierewicz, F.; Preat, V.; Hoffman, M.; Maincent, P. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Biomaterials 1996, 17, 2191–2197.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.